(19)
(11) EP 4 816 560 A1

(12)

(43) Date of publication:
07.10.2026 Bulletin 2026/41

(21) Application number: 24828930.8

(22) Date of filing: 27.11.2024
(51) International Patent Classification (IPC): 
C12Q 1/6886(2018.01)
(52) Cooperative Patent Classification (CPC):
C12Q 1/6886; C12Q 2600/106; C12Q 2600/156
(86) International application number:
PCT/US2024/057771
(87) International publication number:
WO 2025/117756 (05.06.2025 Gazette 2025/23)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 28.11.2023 US 202363603378 P
23.10.2024 US 202463710966 P

(71) Applicant: Gradalis, Inc.
Carrollton, TX 75006 (US)

(72) Inventors:
  • NEMUNAITIS, John
    Carrollton, Texas 75006 (US)
  • BOGNAR, Ernest
    Carrollton, Texas 75006 (US)
  • NEJEDLIK, Laura
    Carrollton, Texas 75006 (US)
  • WALTER, Adam
    Carrollton, Texas 75006 (US)
  • ENGLE, Steven
    Carrollton, Texas 75006 (US)
  • WILLOUGHBY, David
    Carrollton, Texas 75006 (US)

(74) Representative: J A Kemp LLP 
80 Turnmill Street
London EC1M 5QU
London EC1M 5QU (GB)

   


(54) NEOANTIGEN IMMUNOTHERAPY